Home » Topics » Articles » Insight

Insight
RSS

Week in review

June 17, 2019

Word on the street

June 17, 2019

Week in Washington

June 17, 2019

Phase I clinical trials: May 2019

June 17, 2019

Phase II clinical trials: May 2019

June 17, 2019

Public financing of biotechnology companies: Commenced trading in May 2019

June 10, 2019

Public financing of biotechnology companies: Filed and pending IPOs in May 2019

June 10, 2019

Other financings of public biotechnology companies in May 2019

June 10, 2019

Venture capital and other investments in private biotech companies in May 2019

June 10, 2019

BioWorld Stock Index 2019

June 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.